(Q38402732)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

review article

1 reference

title

Young-age prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

Theodorus H Van der Kwast

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

S Hussein

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

S Satturwar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

2 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Pathology

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

511-515

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Cancer of the prostate. Do younger men have a poorer survival rate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Progression after radical prostatectomy for men in their thirties compared to older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Genome-wide association scan for variants associated with early-onset prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Early onset prostate cancer has a significant genetic component

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Prostate cancer in young men: an important clinical entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

BRCA2 mutation in Icelandic prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Germline mutations in HOXB13 and prostate-cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-202993

10.1136/JCLINPATH-2015-202993

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json

release_rjnkotilg5a2pgmidqefifooti

4 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rjnkotilg5a2pgmidqefifooti

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25837493%20AND%20SRC:MED&resulttype=core&format=json